Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Procter & Gamble HealthBOM:500126 -1.79%76 Dividend Yield % is 2.73% as of Sep. 03, 2026, which is 144% above its 10-year median of 1.12. GuruFocus rates BOM:500126 with a GF Score™ of 76/100 and a GF Value™ of ₹5,780.35 (Fairly Valued). The stock has 2 warning signs investors should review. Among 508 Drug Manufacturers companies, Procter & Gamble Health ranks better than 61.81% on this metric.
As of today (2026-09-03), the Trailing Annual Dividend Yield of Procter & Gamble Health is 2.73%.
The historical rank and industry rank for Procter & Gamble Health's Dividend Yield % or its related term are showing as below:
BOM:500126'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.35 Med: 1.12 Max: 3.32
Current: 2.73
During the past 13 years, the highest Dividend Yield of Procter & Gamble Health was 3.32%. The lowest was 0.35%. And the median was 1.12%.
BOM:500126's Dividend Yield % is ranked better than 61.81% of 508
companies
in the Drug Manufacturers industry
Industry Median: 2
vs BOM:500126: 2.73
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Procter & Gamble Health Ltd is 0.79, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Procter & Gamble Health was 0.79. The lowest was 0.15. And the median was 0.40.
During the past 12 months, Procter & Gamble Health's average Dividends Per Share Growth Rate was 10.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 24.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 39.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 38.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Procter & Gamble Health was 79.20% per year. The lowest was -72.10% per year. And the median was 35.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Procter & Gamble Health (BOM:500126) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Health Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Health's Dividend Yield % falls into.
Procter & Gamble Health Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Procter & Gamble Health Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 45.000000
2026-08-27
2026-08-27
2026-09-27
Cash Dividend
semi-annually
INR:INR 1.000000
INR 110.000000
2026-02-12
2026-02-12
2026-02-26
Cash Dividend
semi-annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Health (BOM:500126) has a Dividend Yield % of 2.73% as of Sep. 03, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Procter & Gamble Health and its competitors. This is 144% above median its historical median of 1.12. Over the past decade, Procter & Gamble Health's Dividend Yield % has ranged from 0.35 to 3.32. According to the industry distribution chart, Procter & Gamble Health ranks #194 out of 508 companies in the Drug Manufacturers industry, placing it in the top 38.2%.
Is Procter & Gamble Health's Dividend Yield % too high?
Procter & Gamble Health's current Dividend Yield % of 2.73% is 144% above median its 10-year median of 1.12. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 3.32. The Drug Manufacturers industry median Dividend Yield % is 2.00. Procter & Gamble Health's value of 2.73% is 36.5% above this industry median. Based on the distribution chart, Procter & Gamble Health ranks #194 out of 508 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Procter & Gamble Health has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Health's Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Procter & Gamble Health ranks #194 out of 508 companies for Dividend Yield %. This puts Procter & Gamble Health in the upper half of its industry. The industry median Dividend Yield % is 2.00. Procter & Gamble Health's value of 2.73% is 36.5% above this benchmark. Historically, Procter & Gamble Health's own Dividend Yield % has ranged from 0.35 to 3.32 over the past decade. While the company's 10-year median is 1.12 vs. the industry median of 2.00, Procter & Gamble Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.00, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Health's current Dividend Yield % of 2.73% is 36.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Procter & Gamble Health and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Health's current Dividend Yield % is 2.73%, which is 144% above median its own 10-year median of 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Health stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Health (BOM:500126) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,780.35, compared to a current price of ₹5,679.10 — trading 1.8% below its estimated fair value. The current Dividend Yield % is 2.73%, which is 144% above median its 10-year median of 1.12 and 36.5% above the Drug Manufacturers industry median of 2.00. Procter & Gamble Health's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Procter & Gamble Health (BOM:500126), the current Dividend Yield % is 2.73% as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Health (BOM:500126) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Health stock appears to be undervalued.
The current stock price of ₹5,679.10 is trading 1.8% below its estimated GF Value™ of ₹5,780.35.
GuruFocus considers Procter & Gamble Health to be Fairly Valued.
Key valuation signals for BOM:500126:
Dividend Yield %: 2.73% (144% above median its 10-year median of 1.12)
GF Value™: ₹5,780.35 vs. price of ₹5,679.10 (1.8% below fair value)
Industry Position: 36.5% above the Drug Manufacturers median (#194 of 508)
No single metric tells the full story. See the BOM:500126 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
76GF Score
Get the complete analysis for BOM:500126
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500126 has been successfully added to your 
